LEFT VENTRICULAR HYPERTROPHY REGRESSION DURING ANTIHYPERTENSIVE TREATMENT IN RESISTANT HYPERTENSION PATIENTS

Resistant Hypertension ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

PS 14-14 24-HOUR URINARY SODIUM PREDICTS LEFT VENTRICULAR HYPERTROPHY REGRESSION TO SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION

Journal of Hypertension ◽

10.1097/01.hjh.0000501137.89196.c4 ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e438

Author(s):

Suzanne Oparil ◽

Lama Ghazi ◽

Krishna Gaddam ◽

Eduardo Pimenta ◽

Louis Dell’Italia ◽

...

Keyword(s):

Resistant Hypertension ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Urinary Sodium ◽

Left ventricular hypertrophy regression with antihypertensive treatment: focus on candesartan

Blood Pressure ◽

10.1080/08038020310020670 ◽

2003 ◽

Vol 12 (sup2) ◽

pp. 5-15 ◽

Cited By ~ 3

Author(s):

Cesare Cuspidi ◽

Gastone Leonetti ◽

Alberto Zanchetti

Keyword(s):

Ventricular Hypertrophy ◽

Left Ventricular ◽

Treatment Focus ◽

Left ventricular hypertrophy regression during antihypertensive treatment

The Clinical Investigator ◽

10.1007/bf00207616 ◽

1992 ◽

Vol 70 (S2) ◽

Cited By ~ 1

Author(s):

H. Eichstaedt ◽

O. Danne ◽

R.J. Schroeder ◽

D. Kreuz

Keyword(s):

Ventricular Hypertrophy ◽

Left Ventricular ◽

High dietary sodium blunts effects of mineralocorticoid receptor antagonism on left ventricular hypertrophy regression in patients with resistant hypertension

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2016.03.002 ◽

2016 ◽

Vol 10 (4) ◽

pp. e1

Author(s):

Lama Ghazi ◽

Krishna K. Gaddam ◽

Eduardo Pimenta ◽

Louis Dell'Italia ◽

Steven G. Lloyd ◽

...

Keyword(s):

Resistant Hypertension ◽

Mineralocorticoid Receptor ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Dietary Sodium ◽

Receptor Antagonism ◽

Mineralocorticoid Receptor Antagonism ◽

Left ventricular hypertrophy regression with angiotensin converting enzyme inhibitor antihypertensive treatment depends on the dipping status and left ventricular geometry pattern

American Journal of Hypertension ◽

10.1016/s0895-7061(03)00551-x ◽

2003 ◽

Vol 16 (5) ◽

pp. A176-A177

Author(s):

G VYSSOULIS

Keyword(s):

Angiotensin Converting Enzyme ◽

Ventricular Hypertrophy ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Left Ventricular Geometry ◽

Converting Enzyme ◽

Ventricular Geometry ◽

Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)

Journal of the American Heart Association ◽

10.1161/jaha.116.004152 ◽

2017 ◽

Vol 6 (3) ◽

Cited By ~ 40

Author(s):

Mai Tone Lønnebakken ◽

Raffaele Izzo ◽

Costantino Mancusi ◽

Eva Gerdts ◽

Maria Angela Losi ◽

...

Keyword(s):

Outpatient Clinic ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Gender differences in left ventricular hypertrophy regression after renal denervation in patients with resistant hypertension

Siberian Medical Journal ◽

10.29001/2073-8552-2019-34-4-128-135 ◽

2020 ◽

Vol 34 (4) ◽

pp. 128-135

Author(s):

E. S. Sitkova ◽

V. F. Mordovin ◽

T. M. Ripp ◽

S. E. Pekarskiy ◽

T. R. Ryabova ◽

...

Keyword(s):

Gender Differences ◽

Resistant Hypertension ◽

Renal Denervation ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study)

Journal of Human Hypertension ◽

10.1038/sj.jhh.1001718 ◽

2004 ◽

Vol 18 (6) ◽

pp. 417-422 ◽

Cited By ~ 15

Author(s):

E Gerdts ◽

M J Roman ◽

V Palmieri ◽

K Wachtell ◽

G Smith ◽

...

Keyword(s):

Ventricular Hypertrophy ◽

Left Ventricular ◽

Life Study ◽

P3231 The favorable effect of weight loss on the cardiac sympatho-vagal drive is the main determinant of the left-ventricular hypertrophy regression in the obese patients

European Heart Journal ◽

10.1016/s0195-668x(03)95857-x ◽

2003 ◽

Vol 24 (5) ◽

pp. 608

Author(s):

S NODARI

Keyword(s):

Weight Loss ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Favorable Effect ◽

Obese Patients ◽

Main Determinant ◽

Faculty Opinions recommendation of Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14254959.15769062 ◽

2012 ◽

Author(s):

Luis Ruilope ◽

Jose Antonio García Donaire

Keyword(s):

Cardiac Function ◽

Resistant Hypertension ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Sympathetic Denervation ◽

Renal Sympathetic Denervation ◽

Renal Sympathetic